PDCD1 and neoplasm: Unfortunately, tumor exosomes carrying PD-L1 can inhibit T cells even when PD-1 inhibitors are bound to PD-1 on T cells, thus effectively bypassing the immune checkpoint blockade and allowing the cells to evade immune surveillance [111].